Liberty Biopharma (CVE:LTY) Stock Passes Below Fifty Day Moving Average – Time to Sell?

Liberty Biopharma Inc (CVE:LTY) shares crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.

Liberty Biopharma Stock Up ∞

The firm has a 50-day simple moving average of C$2.00 and a 200 day simple moving average of C$2.00. The stock has a market capitalization of C$21.54 million and a P/E ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12.

About Liberty Biopharma

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.